A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the effect of an investigational drug versus placebo
on bone loss in men with prostate cancer who are receiving Androgen Deprivation Therapy
(ADT). The study drug or placebo will be administered every three months of four treatments
in one year.
In order to participate, male patients 18 years and older must be consecutive veterans from
participating Veterans Administration Medical Centers.